Jens Kildal
@Dnb Asset Management As
Latest period2024 - Q3ReportedManaged Assets$22.15BTotal holdings715
Assets growth rate5.68%Assets growth rate (2-Q avg)7.49%Continuous growth in asset value2 quarters
Portfolio positions
This chart displays the top 10 holdings in Dnb Asset Management As's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 715 positions.
Assets under management
The assets under management (AUM) of Dnb Asset Management As over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 22.15B in assets, with a quarterly growth rate of 5.68% and a 2-quarter average growth rate of 7.49%. The portfolio is managed by Jens Kildal, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BPMCBlueprint Medicines Corp
| 0.01% | $805,953 8,713 shares@ $92.51 avg price | New Position |
GLBEGlobal E Online Ord
| 0.01% | $682,810 17,763 shares@ $38.45 avg price | New Position |
PCVXVaxcyte Inc
| 0.01% | $664,079 5,812 shares@ $114.26 avg price | New Position |
SMMTSummit Therapeutics Inc
| 0.01% | $630,063 28,770 shares@ $21.9 avg price | New Position |
CRSPCrispr Therapeutics Ag
| 0.01% | $555,069 11,815 shares@ $46.99 avg price | New Position |
BEAMBeam Therapeutics Inc
| 0.01% | $509,576 20,799 shares@ $24.51 avg price | New Position |
XPXp Inc
| 0.01% | $505,298 28,166 shares@ $17.94 avg price | New Position |
ALKSAlkermes Plc
| 0.01% | $415,064 14,829 shares@ $28.0 avg price | New Position |
LILMFLilium N V
| 0.01% | $379,549 490,183 shares@ $0.78 avg price | New Position |
GERNGeron Corp
| 0.01% | $356,280 78,649 shares@ $4.54 avg price | New Position |